Brandon Smith
Partner at Childers, Schlueter & Smith, LLC
I’m M. Brandon Smith, a partner at Childers, Schlueter & Smith in Atlanta, Georgia, helping injured people nationwide with pharmaceutical litigation, mass torts, product liability, and serious personal injury cases.
Posts
-
Do You Really Need Low T? (Testosterone Supplements)
Prescription medications for low testosterone levels, also known as “Low T” have been heavily advertised to U.S. men in recent years, and as a result, the sale of testosterone replacement treatments have risen substantially during the last 10 years. What is Testosterone? Testosterone is a…
-
Helping Bring Holiday Cheer and Toys To Deserving Children
Our firm is proud to be a part of the Boys and Girls Club’s 2014 holiday gift program. We are helping to ensure that 50 children in need receive gifts this Holiday Season. We are also sponsoring two deserving families in need of help. We…
-
Has Purdue Met Its Match? OxyContin Case Goes to Trial in Kentucky
Purdue, maker of the painkiller OxyContin, has won dismissals in over 400 personal injury lawsuits related to the medication, has settled product liability cases involving the drug without disclosing the terms, and has defeated more than ten class actions suits brought against it over the…
-
Did Takata Know But Fail to Disclose Airbag Problems in 2004?
Former Takata employees have charged that the Japanese airbag manufacturer conducted secret tests in 2004 on 50 airbags retrieved from scrapyards, saying that tests were performed after work hours, on weekends, and holidays during the summer of 2004 at the company’s American headquarters in Auburn…
-
Study Questions Potential Healthcare Savings Gained by Tort Reform
Although many proponents of tort reform believe that fear of malpractice lawsuits prompts physicians to order unnecessary tests and indirectly drives up medical costs, a Rand Corporation study recently published in the New England Journal of Medicine found otherwise. The study analyzed the experienc
-
FDA Announces Import Reforms to Crack Down on Careless Drugmakers
The U.S. Food and Drug Administration is unleashing a barrage of quality-control initiatives aimed at overseas drug manufacturing, potentially empowering prosecutors who choose to target those companies with sloppy production techniques. The campaign played a large part in FDA Commissioner Margaret
-
Blood Thinner Xarelto Said To Cause Internal Bleeding
Virginia Stuntebeck sued Johnson & Johnson and Bayer AG in Pennsylvania court earlier this year, alleging that she suffered severe internal bleeding stemming from use of the blood-thinning drug Xarelto. In the Xarelto lawsuit, which appears to be the first tort suit filed over the…
-
New Study Results Consistent with Claims Against Stryker Corp. For Failed Hip Implants
Our personal injury lawyers have been investigating claims on behalf of those that have had revision surgeries as a result of metal hip implant complications since the Stryker Rejuvenate modular-neck stem implant recall nearly two years ago. In July 2012, the Stryker Corporation issued a…
-
Xarelto Among Group of Highly Dangerous Drugs
Anticoagulants such as Xarelto are considered by many to be among the most dangerous drugs because of the high number of serious side effects that are being reported to the U.S. Food and Drug Administration. Xarelto belongs to a class of anticoagulants called direct factor…
-
Xarelto Lawsuits Show Rise In Uncontrolled Bleeding Risks
Xarelto, Bayer’s blood thinner formulated to prevent blood clots and lower the risk of stroke, may also cause uncontrolled bleeding that can lead to hospitalization and even death. Xarelto is an anticoagulant developed by Bayer and Johnson & Johnson’s New Jersey-based unit, Janssen Pharmaceuticals.
Subscribe to Brandon Smith
Get new posts delivered to your inbox.